Research Studies

Browse the list of research studies by Center / Program and specialty areas.

G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Term Follow up (GOAL- e2)
Status: Active - Enrolling.
Read More... 

Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Active - Enrolling.
Read More...

A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis
Status: Active - Enrollment complete.
Read More...

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Active - Enrolling.
Read More...

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis (OPTIMIZE)
Status: Waiting activation to start enrolling subjects.
Read More...

Pending IRB approval.

FG-3019-049 (Fibrogen): A Phase 2a, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Efficacy of FG-3019 in Subjects with Idiopathic Pulmonary Fibrosis
Status: Active - Enrolling.
Read More... 

PANTHER (NHLBI / Duke): Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in People With Idiopathic Pulmonary Fibrosis
Status: Active - Enrolling.
Read More...

PIPF-012 (InterMune): An Open-Label Extension Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Active - Enrolling.
Read More...

PIPF-016 (Intermune): A Randomized, Double Blind, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Status: Active - Enrolling.
Read More...

The MIND-USA Study: Modifying the Impact of ICU-Associated Neurological
Status: Active - Enrolling.
Read More...

ASC01 - A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Status: Active - Enrolling.
Read More...

COMPASS2 - Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Status: Active - Closed to Enrollment.
Read More...

RENEW (PneumRx): Lung Volume Reduction Coil for Treatment in Patients With Emphysema (RENEW) Study.
Status: Active - Enrolling
Read More...

ASPIRE (Aeris): Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE).
Status: Active - Enrolling
Read More...

ASAP (CareFusion/Duke): Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter on the Incidence of Auto-Pleurodesis in Patients With Malignant Pleural Effusions.
Status: Active - Enrolling
Read More...

ADX-0001 (Allegro): Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer.
Status: Active - Closed to Enrollment
Read More...